The Journal of Pediatrics
Volume 146, Issue 1 , Pages 45-53 , January 2005

Growth hormone (GH) treatment to final height in children with idiopathic short stature: Evidence for a dose effect

Received 6 January 2004 ,Revised 12 July 2004 ,Accepted 23 August 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 G. B. Cutler, B. Crowe, T. J. Beck, K. Roberts, and A. Gill are employees and shareholders of Eli Lilly and Company, which sponsored this study. A. Attanasio is a consultant to and shareholder of Eli Lilly and Company. J. M. Wit, J.-L. Chaussain, H. Frisch, and R. Yturriaga were all principal investigators for this study.

PII: S0022-3476(04)00794-2

doi: 10.1016/j.jpeds.2004.08.055

The Journal of Pediatrics
Volume 146, Issue 1 , Pages 45-53 , January 2005

Article Tools

* Image Usage & Resolution